Evidence map›Paper›PMID 34483788›Full record

ArticleVacunas2022

Factors influencing the acceptability of COVID-19 vaccination: A cross-sectional study from Malaysia.

R R Marzo, A Ahmad, K Abid, A P Khatiwada, A Ahmed, T M Kyaw, I B Z Abidin, M Srithar, S Sinnathamby, A P Sarvasundram and 1 more

Abstract read
In one paragraph

Article in Vacunas, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A survey on Malaysian's acceptance and perceptions towards COVID-19 booster dose.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

R R MarzoDepartment of Community Medicine, International Medical School, Management and Science University, Selangor, Malaysia.
A AhmadDepartment of Community Medicine, Manipal Tata Medical College, Manipal Academy of Higher Education, Jamshedpur, India.
K AbidDepartment of Public Health, The Shaheed Zulfikar Ali Bhutto Institute of Science and Technology, Karachi, Pakistan.
A P KhatiwadaDepartment of Pharmaceutical and Health Service, Nepal Health Research and Innovation Foundation, Province Bagmati, Lalitpur, Nepal.
A AhmedSchool of Pharmacy, Monash University Malasya, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor, Malaysia.
T M KyawDepartment of Community Medicine, Faculty of Medicine, Asia Metropolitan University, Johor, Malaysia.
I B Z AbidinDepartment of Community Medicine, Faculty of Medicine, Asia Metropolitan University, Johor, Malaysia.
M SritharDepartment of Community Medicine, Faculty of Medicine, Asia Metropolitan University, Johor, Malaysia.
S SinnathambyDepartment of Community Medicine, Faculty of Medicine, Asia Metropolitan University, Johor, Malaysia.
A P SarvasundramDepartment of Community Medicine, Faculty of Medicine, Asia Metropolitan University, Johor, Malaysia.
S ShresthaSchool of Pharmacy, Monash University Malasya, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the surge of COVID-19 cases worldwide, vaccines against COVID-19 are also developing across the countries. However, the acceptability of COVID-19 vaccination among general people is questionable. The availability of several vaccines' options against COVID-19 has perplexed people regarding individual vaccines' efficacy and safety. Therefore, we aim to determine the acceptance, preferences, impact factors of future COVID-19 vaccines in Malaysia and the factors influencing the COVID-19 vaccination acceptance among vaccine demand and vaccine delay groups. Material and methods: An online-based cross-sectional survey was conducted among Malaysian residents 18 years and above of either gender using the snowball sampling technique. A self-administered questionnaire was made available to participants through various social media networks, email, and telegram. The data obtained from the survey were analyzed using SPSS version 25.0. Association between background characteristics and respondents were analyzed using the Chi-square test in the vaccine delay group and vaccine acceptance group. Results: Total of 1282 responses were considered for the study, mainly from male respondents (71%). Among the respondents, 95.9% thought that vaccination would be an effective way to prevent and control COVID-19, and 96% would accept vaccination if the COVID-19 vaccine were successfully developed and approved for listing in the future. Essential factors influencing vaccination decisions were vaccine convenience (95.7%) and doctor's recommendation (97.3%). Bivariate analysis revealed that age less than 24 years, Malay race, living in urban areas, tertiary education, students, single marital status, family income (Malaysian ringgits) RM 4,850 to RM 10,959 and >RM 10,960 were significantly associated with vaccine acceptance of COVID19 vaccination. Conclusion: All the factors influencing COVID-19 vaccine acceptance rates throughout the country should be studied on a larger scale, and appropriate steps to ensure vaccine acceptance among the public should be meticulously devised by the government and related authorities.

Indexed as

COVID-19MalaysiaSouth AsiaVaccine acceptanceVaccine hesitancy

Identifiers

PMID34483788
PMCPMC8407950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.